Want to join the conversation?
In 2Q16, $MNK posted net sales of $535MM in its Specialty Brands segment, an increase of 60% from 2Q15. In the Specialty Generics segment, net sales decreased 27.1% to $264.4MM, driven principally by net sales declines in various product categories due to increased competition. Net sales for the Nuclear Imaging segment were $102.2MM.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.